InsiderDB

Lobbying disclosures · Lobbying report

TFX: second_quarter 2026 lobbying report

Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members. Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.

Follow TFX
Became public
Jul 13, 2026, 9:18 AM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 6:29 PM EST

Why this is connected

Legal-name match: TELEFLEX INCORPORATED is TELEFLEX INC (https://www.sec.gov/Archives/edgar/data/96943/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported lobbying amounts

Income: $20,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/d5d388d9-3ccd-457c-b2d8-29710738046b/","filing_uuid":"d5d388d9-3ccd-457c-b2d8-29710738046b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d5d388d9-3ccd-457c-b2d8-29710738046b/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-07-13T09:18:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":66262,"url":"https://lda.gov/api/v1/clients/66262/","client_id":66262,"name":"TELEFLEX INCORPORATED","general_description":"Medical technologies","client_government_entity":null,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-01"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139293,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139293,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

+0.66% TFX

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in TFX

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.